Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study.
作者信息
Esposito Anthony J, Menon Aravind A, Ghosh Auyon J, Putman Rachel K, Fredenburgh Laura E, El-Chemaly Souheil Y, Goldberg Hilary J, Baron Rebecca M, Hunninghake Gary M, Doyle Tracy J
机构信息
Brigham and Women's Hospital Boston, Massachusetts.
出版信息
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1710-1713. doi: 10.1164/rccm.202006-2441LE.
Abstract
摘要
相似文献
1
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case-Control Study.间质性肺疾病合并新型冠状病毒肺炎患者死亡几率增加：一项病例对照研究
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1710-1713. doi: 10.1164/rccm.202006-2441LE.
2
Cardiovascular comorbidity and death from COVID-19: Prevalence and differential characteristics.心血管合并症与 COVID-19 死亡：患病率及差异特征。
Cardiol J. 2021;28(2):339-341. doi: 10.5603/CJ.a2021.0023. Epub 2021 Feb 26.
3
Mitral Annular Plane Systolic Excursion: An Early Marker of Mortality in Severe COVID-19.二尖瓣环平面收缩期位移：重症 COVID-19 患者死亡的早期标志物。
J Am Soc Echocardiogr. 2020 Nov;33(11):1411-1413. doi: 10.1016/j.echo.2020.08.012. Epub 2020 Aug 18.
4
COVID-19 pneumonia can cause irreversible lung damage in dermatomyositis with pre-existing interstitial lung disease.新冠病毒肺炎可在已有间质性肺病的皮肌炎患者中导致不可逆的肺损伤。
Int J Rheum Dis. 2021 Sep;24(9):1221-1223. doi: 10.1111/1756-185X.14204. Epub 2021 Aug 9.
5
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease.支气管肺泡灌洗在疑似新型冠状病毒肺炎反复核酸检测阴性及间质性肺疾病中的应用价值
J Glob Antimicrob Resist. 2020 Dec;23:67-69. doi: 10.1016/j.jgar.2020.07.030. Epub 2020 Aug 15.
6
Prognostic performance of CHA₂DS₂-VASc scores for predicting mortality among COVID-19 patients: A single pandemic center experience.CHA₂DS₂-VASc评分对预测COVID-19患者死亡率的预后性能：单一大流行中心经验
Am J Emerg Med. 2021 Jul;45:635-637. doi: 10.1016/j.ajem.2020.11.026. Epub 2020 Nov 18.
7
Severity predictors in pediatric SARS-CoV-2 and MIS-C.儿童新冠病毒（SARS-CoV-2）及儿童多系统炎症综合征（MIS-C）的严重程度预测指标
J Pediatr. 2021 May;232:307-310. doi: 10.1016/j.jpeds.2021.02.057.
8
Early mortality in hip fracture patients admitted during first wave of the COVID-19 pandemic in Northern Italy: a multicentre study.意大利北部新冠疫情第一波期间收治的髋部骨折患者的早期死亡率：一项多中心研究
J Orthop Traumatol. 2021 Apr 5;22(1):15. doi: 10.1186/s10195-021-00577-9.
9
International Medical Graduate Physician Deaths From COVID-19 in the United States.国际医学毕业生医师在美国因 COVID-19 死亡。
JAMA Netw Open. 2021 Jun 1;4(6):e2113418. doi: 10.1001/jamanetworkopen.2021.13418.
10
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
引用本文的文献
1
Clinical impacts of COVID-19 on severe exacerbation and mortality in interstitial lung disease: prognosis 30 days after infection.新型冠状病毒肺炎对间质性肺疾病严重加重和死亡率的临床影响：感染后30天的预后
Korean J Intern Med. 2025 Jul;40(4):634-644. doi: 10.3904/kjim.2024.388. Epub 2025 Jul 1.
2
Association of vaccination status and immunosuppression with mortality of SARS-CoV-2 infection in patients with fibrotic interstitial lung disease.纤维化间质性肺疾病患者的疫苗接种状况和免疫抑制与SARS-CoV-2感染死亡率的关联
BMJ Open Respir Res. 2025 Jun 24;12(1):e003008. doi: 10.1136/bmjresp-2024-003008.
3
Clinical impact of idiopathic pulmonary fibrosis on SARS-CoV-2 patient outcomes: a comprehensive analysis in the pre-vaccination era.特发性肺纤维化对感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）患者预后的临床影响：疫苗接种前时代的综合分析
Front Med (Lausanne). 2025 May 21;12:1567232. doi: 10.3389/fmed.2025.1567232. eCollection 2025.
4
Impact of sarcopenia and obesity on mortality in older adults with SARS-CoV-2 infection: automated deep learning body composition analysis in the NAPKON-SUEP cohort.肌少症和肥胖对感染新型冠状病毒的老年人死亡率的影响：NAPKON-SUEP队列中的自动深度学习身体成分分析
Infection. 2025 May 16. doi: 10.1007/s15010-025-02555-3.
5
COVID-19 caused by the Omicron variant in lung transplant recipients: a single center case series.肺移植受者中由奥密克戎变异株引起的 COVID-19：单中心病例系列
J Thorac Dis. 2025 Feb 28;17(2):576-592. doi: 10.21037/jtd-24-1314. Epub 2025 Feb 27.
6
COVID-19 infection and pulmonary sarcoidosis: a systematic review and meta-analysis of morbidity, severity and mortality.新型冠状病毒肺炎感染与肺结节病：发病率、严重程度及死亡率的系统评价与荟萃分析
J Thorac Dis. 2025 Feb 28;17(2):744-752. doi: 10.21037/jtd-24-1620. Epub 2025 Feb 27.
7
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study.中国奥密克戎毒株流行期间特发性炎性肌病患者的新冠病毒病结局：一项纵向观察性研究
PLoS One. 2025 Feb 10;20(2):e0317319. doi: 10.1371/journal.pone.0317319. eCollection 2025.
8
Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients.对接种新冠疫苗的特发性肺纤维化患者免疫活性的综合分析。
Front Immunol. 2025 Jan 8;15:1436491. doi: 10.3389/fimmu.2024.1436491. eCollection 2024.
9
Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients.接种 SARS-CoV-2 疫苗对 IPF 患者心理健康的有益影响。
Adv Respir Med. 2024 Nov 6;92(6):466-471. doi: 10.3390/arm92060042.
10
Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data.基于 SARS-CoV-2 基因组多样性的 COVID-19 严重程度的可预测性和可解释性增强：一项涵盖四年数据的综合研究。
Sci Rep. 2024 Nov 6;14(1):26992. doi: 10.1038/s41598-024-78493-1.
本文引用的文献
1
Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.患有间质性肺病和肺结节病的患者因新型冠状病毒肺炎面临患重症的高风险。
Cleve Clin J Med. 2020 Jun 18. doi: 10.3949/ccjm.87a.ccc026.
2
Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.COPD 与 COVID-19 患者吸烟的流行率、严重程度和死亡率：一项快速系统评价和荟萃分析。
PLoS One. 2020 May 11;15(5):e0233147. doi: 10.1371/journal.pone.0233147. eCollection 2020.
3
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.皮质类固醇治疗对 SARS-CoV-2、SARS-CoV 或 MERS-CoV 感染患者结局的影响：系统评价和荟萃分析。
Leukemia. 2020 Jun;34(6):1503-1511. doi: 10.1038/s41375-020-0848-3. Epub 2020 May 5.
4
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
5
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
6
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.《中国 2019 年冠状病毒病（COVID-19）的临床特征：系统评价和荟萃分析》
J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.
7
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
8
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.合并症的患病率及其对 SARS-CoV-2 感染患者的影响：系统评价和荟萃分析。
Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12.
9
The Role of Infection in Interstitial Lung Diseases: A Review.感染在间质性肺疾病中的作用：综述
Chest. 2017 Oct;152(4):842-852. doi: 10.1016/j.chest.2017.03.033. Epub 2017 Apr 8.
Zotero 插件